Anticancer treatment of endostatin gene therapy by targeting tumor neovasculature in C57/BL mice

Clinical Hemorheology and Microcirculation

Volumn 23, Issue 2-4, 2000, Pages 251-257

  Jia, Shidong ^a,b   Zhu, Fuxiang ^b   Li, Hongwei ^a   He, Fuchu ^b   Xiu, Ruijuan ^a  

^a Chinese Academy of Medical Sciences   (China)

^b CHINESE NATIONAL HUMAN GENOME CENTER AT SHANGHAI   (China)

Author keywords

Angiogenesis; Endostatin; Gene therapy; Tumor

Indexed keywords

ANGIOGENESIS INHIBITOR; ENDOSTATIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; CANCER; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; GENE TARGETING; GENE THERAPY; GROWTH INHIBITION; IMMUNOHISTOCHEMISTRY; LUNG METASTASIS; MOUSE; NICK END LABELING; NONHUMAN; TUMOR GROWTH; TUMOR VASCULARIZATION;

ANGIOGENESIS INHIBITORS; ANIMALS; CARCINOMA, LEWIS LUNG; CELL DIVISION; CERCOPITHECUS AETHIOPS; COLLAGEN; COS CELLS; DNA, COMPLEMENTARY; DRUG SCREENING ASSAYS, ANTITUMOR; ENDOSTATINS; ENDOTHELIUM, VASCULAR; FEMALE; GENE THERAPY; GENETIC VECTORS; HUMANS; INJECTIONS, INTRAMUSCULAR; LUNG NEOPLASMS; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; NEOPLASM METASTASIS; NEOVASCULARIZATION, PATHOLOGIC; PEPTIDE FRAGMENTS; RECOMBINANT FUSION PROTEINS; TRANSFECTION;

EID: 0034455374     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (15)

1. J. Folkman, Angiogenesis in cancer, vascular, rheumatoid and other disease, Nat. Med. 1 (1995), 27-31.
2. J. Folkman, Antiangiogenic gene therapy, Proc. Natl. Acad. Sci. USA 95 (1998), 9064-9066.
3. M.S. O'Reilly, T. Boehm, Y. Shing et al., Endostatin: an endogenous inhibitor of angiogenesis and tumor growth, Cell 88 (1997), 277-285.
4. M.S. O'Reilly, L. Holmgren, C. Chen et al., Angiostatin induces and sustains dormancy of human primary tumors in mice, Nat. Med. 2 (1996), 689-692.
5. R.J. Mumper, J.G. Duguid, K. Anwer et al., Polyvinyl derivatives as novel interactive polymers for controlled gene delivery to muscle, Pharm. Res. 13 (1996), 701-709.
6. P. Blezinger, J. Wang, M. Gondo et al., Systemic inhibition of tumor growth and tumor metastasis by intramuscular administration of the endostatin gene, Nat. Biotech. 17 (1999), 343-348.
7. P. Lin, J.A. Buxton, A. Acheson et al., Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2, Proc. Natl. Acad. Sci. USA 95 (1998), 8829-8834.
8. A. Goldin et al., Current results of the screening program at the division of cancer treatment, National Cancer Institute, Eur. J. Cancer 17 (1981), 129-142.
9. M. Tsujii et al., Cyclooxygenase regulates angiogenesis induced by colon cancer cells, Cell 93 (1998), 705-716. [Erratum: Cell 94 (1998), 271].
10. Y. Kamagata, Y. Muragaki et al., Isolation and sequencing of cDNAs for proteins with multiple domains of Gly-Xaa-Yaa repeats identify a distinct family of collagenous proteins, Proc. Natl. Acad. Sci. USA 91 (1994), 4229-4233.
11. M. Dhanabal, R. Ramchandran, J.F. Matthew et al., Endostatin induces endothelial cell apoptosis, J Bio. Chem. 274 (1999), 11721-11726.
12. P.R. Colville-Nash and D.L. Scott, Angiogenesis and rheumatoid arthritis: pathogenic and therapeutic implications, Ann. Rheum. Dis. 51 (1992), 919-925.
13. L.P. Aiello, R.L. Avery, P.O. Arrigg et al., Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders, New Engl. J. Med. 331 (1994), 1480-1487.
14. K. Takahashi, J.B. Mulliken, H.P. Kozakewich et al., Cellular markers that distinguish the phases of hemangioma during infancy and childhood, J. Clin. Invest. 93 (1994), 2357-2364.
15. M. Detmar, L.F. Brown, K.P. Claffey et al., Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis, J. Exp. Med. 180 (1994), 1141-1146.